AstraZeneca and California-based biotech Ionis Pharmaceuticals announce a late-stage trial failure for their gene silencing ...
-AstraZeneca said it expected prescriptions of its COVID therapy to drive sales growth of more than 20% this year, as company ...
AstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions in lawsuits brought by ...
May 28 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday Amgen's (AMGN.O), opens new tab Bkemv, the first biosimilar to AstraZeneca's (AZN.L), opens new tab rare blood disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results